Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Population Based Germline Testing for Early Detection and Prevention of Cancer [NA]
Ongoing study evaluating population-based germline genetic testing for early cancer detection and prevention in individuals at risk for brea…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients [Phase 3]
Phase 3 trial evaluating capivasertib in combination with fulvestrant for locally advanced/inoperable or metastatic HR+/HER2- breast cancer …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Virtual RealiTy and mUsic in the Oncology SEtting - Phase 1 [NA]
This document reports the completed Phase 1 clinical trial evaluating the use of virtual reality and music therapy in the oncology setting f…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer [EARLY_Phase 1]
An early-phase (Phase 1) clinical trial evaluating a HER2-directed dendritic cell vaccine used with neoadjuvant therapy for HER2-positive br…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer [Phase 2]
Phase 2 liquid-biopsy informed platform trial evaluating treatments for CDK4/6-inhibitor resistant ER+/HER2- metastatic breast cancer; recru…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer [Phase 3]
A Phase 3 neoadjuvant trial evaluating TQB2102 for HER2-positive breast cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
The document describes an NCI study using whole exome sequencing to identify causative germline variants in patients with breast cancer who …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
Clinical trial update describing a study that uses whole exome sequencing to identify causative germline variants in patients with periphera…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Well-Being After Breast Cancer Surgery [NA]
Duke University reports completion of a clinical trial evaluating coping skills training for persistent post-surgical pain and general healt…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management [Phase 2]
This is a Phase 2 clinical trial evaluating trastuzumab deruxtecan as first-line therapy for HER2-positive metastatic breast cancer with pro…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
This clinical trial update describes using whole exome sequencing to identify causative germline variants in patients with congestive heart …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of the Use of Text Message Reminders to Take Palbociclib [NA]
This clinical trial update describes a study evaluating whether text message reminders improve adherence to Palbociclib in patients with bre…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 study evaluating an [18F]FPyQCP PET imaging agent targeting fibroblast activation protein across colorectal cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Exemption of SLNB After Neoadjuvant Therapy for Triple-negative and Her2-positive Breast Cancer [NA]
A clinical trial is evaluating whether sentinel lymph node biopsy can be omitted after neoadjuvant therapy in patients with triple-negative …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: AMH Dynamic Changes to Predict Ovarian Reserve in Perimenopausal Breast Cancer
This clinical trial update describes a study evaluating dynamic changes in anti-Müllerian hormone (AMH) to predict ovarian reserve in perime…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment [Phase 2]
A Phase 2 clinical trial is evaluating tinengotinib tablets in combination with fulvestrant for HR-positive, HER2-negative recurrent or meta…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Avera Cancer Sequencing and Analytics Protocol (ASAP)
This entry outlines the ASAP cancer sequencing and analytics protocol from Avera Cancer, currently recruiting to study sequencing-based canc…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer [NA]
The trial evaluates contrast-enhanced mammography as a potential predictor of breast cancer, sponsored by MD Anderson Cancer Center. The stu…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Personalized Breast Cancer Screening [NA]
The clinical trial update notes that the personalized breast cancer screening study (NCT06060938) sponsored by Herlev and Gentofte Hospital …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
A recruiting clinical trial to prospectively validate the Ataraxis AI Test for predicting treatment response in neoadjuvant breast cancer.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer [Phase 2]
A Phase 2 clinical trial of Trastuzumab Rezetecan for unresectable locally recurrent or metastatic breast cancer is listed as not yet recrui…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy. [Phase 3]
Phase 3 trial evaluating the efficacy and safety of HRS-8080 in combination with dalpiciclib for locally advanced or metastatic breast cance…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating peri-operative immune checkpoint inhibition with cryoablation in women with triple-negative breast cancer;…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy [NA]
Recruiting trial evaluating hormone replacement therapy after risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Phase 1/2 study of the PARG inhibitor ETX-19477 in patients with advanced solid malignancies is currently recruiting, including breast cance…